FDA accelerates complex generic drug approval process

Food and Drug Administration Commissioner Scott Gottlieb on Monday said the FDA is introducing new policies to streamline the approval process for complex generic drugs, making it easier to bring generic competition to the complex brand-name drug market.

Unlock unlimited access to all Global Competition Review content